Loading...
NPI 1851309595 · Valdosta, GA · Home Infusion Therapy Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
1st America Infusion Services LLC is a home infusion therapy pharmacy provider located in Valdosta, Georgia. This profile covers 2 Medicare and 18 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | 1st America Infusion Services LLC |
| Address | 212 Northside Dr |
| City | Valdosta |
| State | GA |
| ZIP | 31602 |
| Taxonomy | Home Infusion Therapy Pharmacy |
| NPI Enumerated | August 4, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $18.5M |
| Medicare | $219.3K |
1ST AMERICA INFUSION SERVICES LLC is operating as a specialized home infusion therapy pharmacy: its Medicare activity is concentrated in subcutaneous/home infusion administration codes G0069 and G0089, while Medicaid billing is dominated by high-cost injectable therapy (J1599) and time-based home infusion visit codes (99602, 99601). The presence of multiple home-infusion per-diem and supply codes (S9374, S9351, A4222, A4221) and pump codes (E0781) further supports an integrated, in-home infusion service model that bundles drug administration, nursing visits, and durable/consumable supplies. The provider’s profile is consistent with a clinical and logistical operation focused on recurring, home-based infusion care rather than episodic clinic-based services.
Revenue concentration is high on both payers: the precomputed top-three Medicare codes account for 100.0% of this provider’s total Medicare revenue, and the top-three Medicaid codes account for 75.0% of its total Medicaid revenue. This means a small set of services—notably G0069/G0089 on Medicare and J1599/99602/99601 on Medicaid—drive the vast majority of reported payments, concentrating financial exposure in a few clinical lines.
The payer mix is heavily skewed toward Medicaid: reported Medicaid revenue of $18.5M far exceeds Medicare revenue of $219.3K, indicating the provider is effectively Medicaid-dominant in scale. Analysts should treat Medicare activity as a secondary revenue stream for this entity and focus competitive and utilization reviews primarily on Medicaid-funded infusion services.
On the Medicare side the provider is a national high-volume reporter for home subcutaneous administration services: G0069 generated $198.7K (89.8% of the provider’s Medicare revenue) and ranks #2 of 15 nationally (93th percentile; notably above typical national volume), while G0089 generated $22.6K (10.2%) and ranks #1 of 9 nationally (100th percentile; notably above typical national volume). These rankings indicate the practice is an above-typical national outlier for in-home subcutaneous infusion administration among Medicare peers.
Medicaid competitive standing is concentrated and, in several cases, appears to reflect sole or leading in-state reporting: J1599 produced $9.9M (53.9% of Medicaid revenue) and is listed as #1 of 1 in-state (no state peer volume comparison available), and 99602 (20K claims, $2.3M) also ranks #1 of 1 in-state (no state peer volume comparison available). At the same time, some Medicaid codes show typical, unremarkable volumes — for example 99601 ranks #2 of 3 in-state (50th percentile) and S9351 ranks #3 of 4 in-state (33th percentile) — underscoring that where peer data exists the provider’s activity can be either dominant or commonplace depending on the specific service line.
Service-delivery patterns on Medicaid reflect very high visit volumes and routine supply use: the file lists 99601 at 27.5K claims and 99602 at 20K claims, plus substantial claims for supplies and pump management (A4222 8K claims, A4221 12.6K claims, E0781 842 claims). These counts indicate repeated, time-based in-home visits and ongoing supply/pump provisioning are central operational activities, implying significant recurring nursing and pharmacy logistics demand to support patients in the home.
Revenue risk is concentrated in a few high-cost items, most prominently J1599 (Injection, immune globulin), which generated $9.9M and accounts for 53.9% of Medicaid revenue. Such dependence on a single high-cost drug/service line means changes in IVIG utilization, product availability, or reimbursement policy could materially affect the provider’s Medicaid revenue base.
The provider has established tenure in the marketplace, with NPI enumeration on 2006-08-04 (~20 years ago). Long registration combined with concentrated, high-volume code mix suggests an experienced, specialized operator in home infusion services rather than a new or diversified outpatient pharmacy entrant.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0069 | Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's… | 9,460 | $20 | $198.7K |
| G0089 | Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the… | 1,330 | $20 | $22.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 2 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | 4,590 | $2,170 | $9.9M |
| 99602 | The provider visits the patient at home to provide an infusion or administer a specialty drug. Use this code for each additional hour of the visit after the first two hours. | 19,990 | $120 | $2.3M |
| 99601 | The provider visits the patient at home to provide an infusion or administer a specialty drug. Use this code for up to the first two hours of a visit. | 27,540 | $60 | $1.6M |
| S9374 | Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing… | 2,500 | $530 | $1.3M |
| S9351 | Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment… | 1,580 | $720 | $1.1M |
| S9370 | Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing… | 1,600 | $380 | $611.3K |
| S9338 | Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately),… | 15,930 | $40 | $573.6K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 200 | $1,570 | $305.8K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | 8,010 | $30 | $240.2K |
| E0781 | Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient | 840 | $150 | $128.8K |
Showing 1–10 of 18
How this provider's Medicaid billing volume and revenue compare to other Georgia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Georgia median
18 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| S9351 | Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment… | 3 | 10 | 6,150 | $430 | $19.7M |
| J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | 1 | 10 | 4,590 | $2,170 | $9.9M |
| 99601 | The provider visits the patient at home to provide an infusion or administer a specialty drug. Use this code for up to the first two hours of a visit. | 2 | 10 | 27,540 | $100 | $3.1M |
| 99602 | The provider visits the patient at home to provide an infusion or administer a specialty drug. Use this code for each additional hour of the visit after the first two hours. | 1 | 10 | 19,990 | $110 | $2.3M |
| S9374 | Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing… | 1 | 10 | 2,500 | $530 | $1.3M |
| S9370 | Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing… | 1 | 10 | 1,600 | $380 | $611.2K |
| S9338 | Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately),… | 1 | 10 | 15,930 | $40 | $575.1K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2 | 10 | 220 | $2,170 | $466.7K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | 1 | 10 | 8,010 | $30 | $240.6K |
| E0781 | Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient | 1 | 10 | 840 | $150 | $128.7K |
Showing 1–10 of 18
Other providers in the same ZIP code as 1st America Infusion Services LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.